Lobeline

solute carrier family 18 member A2 ; Rattus norvegicus







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29427069 New Scaffold for Lead Compounds to Treat Methamphetamine Use Disorders. 2018 Feb 9 1
2 24484975 The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. 2014 1
3 23875705 Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. 2013 Oct 1
4 20036131 Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters. 2010 Jan 15 3
5 15331654 Lobeline attenuates methamphetamine-induced changes in vesicular monoamine transporter 2 immunoreactivity and monoamine depletions in the striatum. 2005 Jan 1
6 11841781 A novel mechanism of action and potential use for lobeline as a treatment for psychostimulant abuse. 2002 Jan 15 3
7 9648873 Lobeline displaces [3H]dihydrotetrabenazine binding and releases [3H]dopamine from rat striatal synaptic vesicles: comparison with d-amphetamine. 1998 Jul 1